Why should you invest in this smallcase?

As defensives tend to rally in the year before election results. Pharma has long been the underperformer and is currently seeing some triggers supporting a trend reversal. We have seen a strong correlation in US Pharma Index and NSE pharma Index. Currently post a 4 year of consolidation both indices have broken out together. Within the Nifty basket, pharma sector has surprised the most in financial results compared to the other sectors. Margins also have seen improvement in this quarter on an aggregate basis. Eliminating leader bias by using equal weighted chart of 10 stock hints that momentum is picking up in the pharma. 

Know how this smallcase was created


Download key points about this smallcase

Created by Edelweiss Research

Past Performance vs 

Equity Large Cap

Value of ₹ 100 invested once on
inception of this smallcase

Sep 25, 2014

would be
Pharma Trackers
₹ 151.36
Equity Large Cap
₹ 148.55


Past performance doesn't guarantee future returns & is inclusive of all rebalances. Download chart